Data-Driven Insights To Improve Your Recruitment Process For Clinical Trials
By Michael Gebauer and Andreas Krämer
Globally, approximately $186 billion was spent on drug discovery in 2019,
1 with nearly 50 percent of that spent on clinical trials.
2 One of the major challenges in this regard is the recruitment of suitable patients,
3,4 who are sometimes driven by negative attitudes or a lack of education and information about clinical trials in general.
5 However, robust data based on representative research are rare. For example, Trauth et al. (2000) report a willingness to participate of 46 percent (n=489 in the U.S. state of Pennsylvania).
6 A CISCRP study reported a basic willingness to participate of more than 80 percent,